Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$37.53 - $44.22 $938,250 - $1.11 Million
-25,000 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$37.46 - $42.44 $936,500 - $1.06 Million
25,000 New
25,000 $974,000
Q3 2020

Nov 16, 2020

SELL
$38.56 - $48.36 $1.09 Million - $1.37 Million
-28,375 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$44.5 - $52.11 $1.26 Million - $1.48 Million
28,375 New
28,375 $1.38 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Cinctive Capital Management LP Portfolio

Follow Cinctive Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Cinctive Capital Management LP with notifications on news.